Company

Olema Oncology

Biotechnology Research San Francisco, California, United States 140 employees

Employees: 140
Contacts: 3
Emails: 3
Phones: 2

olema.com LinkedIn

Olema Oncology Overview

Headquarters: San Francisco, California, United States
Website: olema.com
Industry: Biotechnology Research
Employees: 140
Founded: 2007
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

pharmaceuticals biotechnology drug development oncology breast cancer nuclear receptors small molecules

About Olema Oncology

Olema Oncology is a cancer medicines company dedicated to impacting breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a differentiated oral medicine known as a complete estrogen receptor antagonist (CERAN) initially in development for metastatic breast cancer. Our pipeline also includes OP-3136, a potent, selective oral inhibitor of the KAT6 pathway. At Olema, we are building a focused team committed to our mission with intention and clarity. Working alongside a talented, passionate group of leaders and advisors, we strive to create better medicines that aim to help patients feel better, longer. For more information, visit us at www.olema.com.

Olema Oncology Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

Olema Oncology Org Chart

Sample employees and titles

Name	Title	Location	Contact
Krishna Singh	Helping Pharmaceutical Company	Boston, Massachusetts, United States	Email Phone
Maribel Teixeira		San Francisco Bay Area, United States	Email Phone
David Kwasha	Chief Executive Officer at Ahaa! (Avril	Sydney, New South Wales, Australia	Email
Shawnte Mitchell	Global C-suite Life Science/biotech	San Francisco Bay Area, United States	View